BMS has bucked the trend for late-stage immuno-oncology studies in prostate cancer in the CheckMate 650 trial Opdivo in combination with CTLA4 inhibitor Yervoy (ipilimumab), which showed modest ...
(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) announced that the New Drug Application or NDA for ipilimumab injection ... repair deficient (dMMR) colon cancer. The NDA acceptance and Priority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback